Cybeats’ cyber deal with top 10 global medical company

SBOM Studio allows medical device manufacturers to understand their software more effectively, including in the third-party and open-source components they deploy, and comply with the FDA's new cybersecurity regulations.

Cybeats. Software Made Certain.
Cybeats. Software Made Certain.
CREDIT: CNW GROUP/CYBEATS TECHNOLOGIES CORP.

Cybeats Technologies Corp., a company offering industry-leading cybersecurity software, is pleased to report a contract renewal for its product, SBOM Studio, with a top 10 global medical device manufacturer (MDM) that has a $70 billion market cap.

The FDA, which oversees medical device security, released new guidelines that stress the importance of Software Bills of Materials (SBOM), for ensuring medical devices remain safe and effective against cyber threats. The guidelines emphasize traceability and leveraging SBOMs to provide a deep understanding of software components, which helps MDM spot risks and weaknesses, leading to more precise and effective cybersecurity practices.

SBOM Studio allows MDM to understand their software more effectively, including in the third-party and open-source components they deploy, and comply with the FDA's new cybersecurity regulations. This contract follows several other engagements from the global top 10 MDM, including from late 20233 and February 20244, all of which help sustain Cybeats' 100% client retention rate, and demonstrate significant product uptake and clear value proposition to the healthcare industry.

"The commercial momentum in the medical device space is very encouraging for Cybeats, especially given the foresight of a product that anticipated the widespread need for SBOM management solutions. This Fortune 500 client choosing to renew their license with SBOM Studio not only further cements our 100% client retention rate but validates the pivotal role of SBOM Studio in fortifying software supply chains in the medical space," says Justin Leger, CEO, Cybeats.

Get curated news on YOUR industry.

Enter your email to receive our newsletters.
Loading...